Article (Scientific journals)
European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees.
Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland et al.
2022In European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), p. 1 - 3
Peer Reviewed verified by ORBi
 

Files


Full Text
s00259-022-06011-4.pdf
Publisher postprint (389.26 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Radiopharmaceuticals; Humans; Radiopharmaceuticals/therapeutic use; Radionuclide Imaging; Societies, Medical; Curriculum; Europe; Nuclear Medicine/education; Nuclear Medicine; Radiology, Nuclear Medicine and Imaging; General Medicine
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Dierckx, Rudi;  Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
Herrmann, Ken;  Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany
Hustinx, Roland  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco
Lassmann, Michael;  Department of Nuclear Medicine, University Würzburg, Würzburg, Germany
Wadsak, Wolfgang;  Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria ; Center for Biomarker Research in Medicine (CBmed GmbH), Graz, Austria
Kunikowska, Jolanta ;  Nuclear Medicine Department, Medical University of Warsaw, ul. Banacha 1 a, 02-097, Warsaw, Poland. jolanta.kunikowska@wum.edu.pl
Language :
English
Title :
European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees.
Publication date :
December 2022
Journal title :
European Journal of Nuclear Medicine and Molecular Imaging
ISSN :
1619-7070
eISSN :
1619-7089
Publisher :
Springer Science and Business Media Deutschland GmbH, Germany
Volume :
50
Issue :
1
Pages :
1 - 3
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
WW has received research grants from ITM S.E., Scintomics, EZAG, Novo Nordisk (all institutional fees), consultancy fees from GE Healthcare (personal fees) and is a part-time employee of CBmed GmbH, Graz, Austria, and a founder and co-owner of MINUTE medical GmbH, Vienna, Austria.KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, personal fees from Debiopharm, personal fees from AstraZeneca, personal fees from Janssen, outside the submitted work.
Available on ORBi :
since 22 August 2023

Statistics


Number of views
44 (2 by ULiège)
Number of downloads
21 (1 by ULiège)

Scopus citations®
 
4
Scopus citations®
without self-citations
3
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi